Solution structure of a neurotrophic ligand bound to FKBP12 and its effects protein dynamics

European Journal of Biochemistry

Volumn 267, Issue 17, 2000, Pages 5342-5355

  Sich, Christian ^a   Improta, Sabina ^a,b   Cowley, David John ^a   Guenet, Chantal ^b   Merly, Jean Pierre ^b   Teufel, Michael ^b   Saudek, Vladimir ^a  

^a Department of Structural Biology and Cheminformatics ^*  (France)

^b SANOFI   (France)

Author keywords

FKBP12; Ligand binding; Nerve regeneration; NMR structure; Protein dynamics

Indexed keywords

FK 506 BINDING PROTEIN; LIGAND; PYRROLIDINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; LIGAND BINDING; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 0033856956     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01551.x     Document Type: Article

References (69)

1. Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structure of their complexes with FKBP12
2. Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506
3. Structure-based design of novel, urea-containing FKBP12 inhibitors
4. 32-Indolyl ether derivatives of ascomycin: Three-dimensional structures of complexes with FK506-binding protein
5. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia
6. FK506 and the role of immunophilins in nerve regeneration
7. Neural actions of immunophilin ligands
8. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506 Rapamycin cyclosporin
9. A nonimmunosuppressant FKBP12 ligand increases nerve regeneration
10. FKBP12-binding domain analogues of FK506 are potent, nonimmunosuppressive neurotrophic agents in vitro and promote recovery in a mouse model of Parkinson's disease
11. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models
12. Molecular recognition of protein-ligand complexes: Applications to drug design
13. Neuroimmunophilin ligands as novel therapeutics for the treatment of degenerative disorders of the nervous system
14. Investigations of neurotrophic inhibitors of FK506 binding protein via Monte Carlo Simulations
15. 15N relaxation studies of the FK506 binding protein: Backbone dynamics of the uncomplexed receptor
16. 15N NMR relaxation studies of the FK506 binding protein: Dynamic effects of ligand binding and implications for calcineurin recognition
17. Conformation of two non-immunosuppressive FK506 analogs when bound to FKBP by isotope-filtered NMR
18. Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins
19. Rapid recording of 2D NMR spectra without phase-cycling: Application to the study of hydrogen exchange in proteins
20. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions
21. 15N HSQC experiments optimized to retain full sensitivity
22. Computer-optimized decoupling scheme for wideband applications and low-level operation
23. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy
24. Heteronuclear three-dimensional NMR spectroscopy: A strategy for the simplification of homonuclear two-dimensional NMR spectra
25. 15N Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: Application to interleukin lb
26. A simple windowless mixing sequence to suppress cross relaxation in TOCSY experiments
27. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity
28. 13C magnetization
29. 13C correlations in H2O samples of proteins
30. Experiments for recording pure-absorption heteronuclear correlation spectra using pulsed field gradients
31. An improved double-tuned and isotope-filtered pulse scheme based on a pulsed field gradient and a wide-band inversion shaped pulse
32. Gradient-enhanced TOCSY experiments with improved sensitivity and solvent suppression
33. Simple, distorsion-free homonuclear spectra of peptides and nucleic acids in water using excitation sculpting
34. 15N relaxation using inverse detected two-dimensional NMR spectroscopy: The central helix is flexible
35. AURELIA, a program for computer-aided analysis of multidimensional NMR spectra
36. Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities
37. Model-building and refinement practice
38. Determination of three-dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms
39. Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints: Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2
40. Floating stereospecific assignment revisited: Application to an 18 kDa protein and comparison with J-coupling data
41. 13C heteronuclear NMR spectroscopy
42. Internal mobility in the partially folded DNA binding and dimerization domains of GAL4: NMR analysis of the N-H spectral density functions
43. Effects of chemical exchange on NMR spectra
44. Proton and nitrogen sequential assignments and secondary structure determination of the human FK506 and rapamycin binding protein
45. Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (Tacrolimus) in unliganded form and in complex with FK506 and rapamycin
46. Discovering high-affinity ligands for proteins SAR NMR
47. Identification by NMR of the binding surface for the histidine-containing phosphocarrier protein HPr on the N-terminal domain of enzyme I of Escherichia coli phosphotransferase system
48. Pilus chaperone FimC-adhesin FimH interactions mapped by TROSY-NMR
49. 2O in protein NMR. Application to sensitivity enhancement and NOE measurements
50. 15N relaxation data exclusively
51. Protein backbone dynamics revealed by quasi spectral density function analysis of amide N-15 nuclei
52. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Analysis of experimental results
53. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. Theory range validity
54. Theory and practice of nuclear spin relaxation in proteins
55. High throughput scintillation proximity assay for the identification of FKBP12 ligands
56. Chemical shifts as a probe of molecular interfaces: NMR studies of DNA binding by three amino-terminal zinc finger domains from transcription factor IIIA
57. The discovery of steroids and other novel FKBP inhibitors using a molecular docking program
58. NMR spectroscopy as a tool for structure-based drug design
59. NMR spectroscopy in structure-based drug design
60. 15N NMR: Comparisons with X-ray data for Fab
61. X-ray structure of calcineurin inhibited immunophilin immunosuppressant FKBPI2-FK506 complex
62. Crystal structure of human calcineurin and the human FKBP12-FK506-calcineurin complex
63. Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR
64. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506
65. An immunophilin that binds M(r) 90 000 heat shock protein: Structural features of a mammalian p59 protein
66. Three-dimensional structure of the immunophilin-like domain of FKBP59 in solution
67. MOLMOL: A program for display and analysis of macromolecular structures
68. Atomic Structure of FKBP-FK506. An immunophilin-immunosuppressant complex